Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-01

FDA Approved: OXCARBAZEPINE — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma Inc.'s oxcarbazepine as an Original Application (ANDA) generic. The drug is indicated for the treatment of partial seizures in adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)